Сравнение на методи
Прегледайте избраните методи един до друг; редовете с разлики са откроени.
| Претегляне с оценка на склонността (PSW / IPW)× | Съгласуване по показател на склонност× | |
|---|---|---|
| Област≠ | Причинно-следствено заключение | Статистика за изследвания |
| Семейство≠ | Regression model | Process / pipeline |
| Година на възникване≠ | 1983 (propensity score); 2003 (efficient IPW estimator) | 1983 |
| Създател≠ | Rosenbaum & Rubin (propensity score); Hirano, Imbens & Ridder (efficient weighting) | Paul Rosenbaum and Donald Rubin |
| Тип≠ | Causal inference / reweighting | Method |
| Основополагащ източник≠ | Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41-55. DOI ↗ | Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗ |
| Други названия≠ | PSW, inverse probability weighting, IPW, propensity-based weighting | PSM, propensity score weighting, covariate balance |
| Свързани≠ | 6 | 3 |
| Резюме≠ | Propensity score weighting is a causal-inference method that reweights observations so that the covariate distributions of treated and untreated units look exchangeable, enabling unbiased estimation of average treatment effects from observational data. Each unit receives a weight that is the inverse of its probability of receiving the treatment it actually received — a strategy formalised by Rosenbaum and Rubin (1983) and given its efficient semiparametric form by Hirano, Imbens and Ridder (2003). | Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias. |
| ScholarGateНабор от данни ↗ |
|
|